Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...
In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.
Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...
A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results